Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Signe Sparre Beck-Nielsen

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Therapeutic Advances in Chronic Disease|September 9, 2022
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and descriptionMaria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Orphanet Journal of Rare Diseases|September 26, 2023
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical dataGema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M Boot, et al.
European Journal of Endocrinology|June 23, 2026
Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemiaSigne Sparre Beck-Nielsen, Gema Ariceta, Annemieke M Boot, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2024
Systematic Review: Efficacy of Medical Therapy on Outcomes Important to Adult Patients With X-Linked HypophosphatemiaDalal S Ali, Reza D Mirza, Farah Alsarraf, et al.
European Journal of Medical Genetics|June 16, 2022
von Hippel-Lindau disease: Updated guideline for diagnosis and surveillanceMarie Louise M Binderup, Maja Smerdel, Line Borgwadt, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Current Practices in Monitoring Children and Adults with X-linked Hypophosphatemia: A Global Survey of Expert ExperienceDalal S Ali, Farah Alsarraf, Hajar Abu Alrob, et al.
Journal of Bone and Mineral Metabolism|March 22, 2025
Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adultsDalal S Ali, Aliya A Khan, Reza D Mirza, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2025
X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice GuidelineDalal S Ali, Thomas O Carpenter, Erik A Imel, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2025
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice GuidelineAliya A Khan, Dalal S Ali, Natasha M Appelman-Dijkstra, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Therapeutic Advances in Chronic Disease|September 9, 2022
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and descriptionMaria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Orphanet Journal of Rare Diseases|September 26, 2023
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical dataGema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M Boot, et al.
European Journal of Endocrinology|June 23, 2026
Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemiaSigne Sparre Beck-Nielsen, Gema Ariceta, Annemieke M Boot, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2024
Systematic Review: Efficacy of Medical Therapy on Outcomes Important to Adult Patients With X-Linked HypophosphatemiaDalal S Ali, Reza D Mirza, Farah Alsarraf, et al.
European Journal of Medical Genetics|June 16, 2022
von Hippel-Lindau disease: Updated guideline for diagnosis and surveillanceMarie Louise M Binderup, Maja Smerdel, Line Borgwadt, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Current Practices in Monitoring Children and Adults with X-linked Hypophosphatemia: A Global Survey of Expert ExperienceDalal S Ali, Farah Alsarraf, Hajar Abu Alrob, et al.
Journal of Bone and Mineral Metabolism|March 22, 2025
Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adultsDalal S Ali, Aliya A Khan, Reza D Mirza, et al.
The Journal of Clinical Endocrinology and Metabolism|February 17, 2025
X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice GuidelineDalal S Ali, Thomas O Carpenter, Erik A Imel, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2025
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice GuidelineAliya A Khan, Dalal S Ali, Natasha M Appelman-Dijkstra, et al.
Pageof 4